Alice M. Boylan, MD
Dr. Alice M. Boylan is a critical care specialist and pulmonologist at the Medical University of South Carolina. As Chief of the Integrated Center of Clinical Excellence Medical Acute, Critical Care & Trauma, she provides care for patients diagnosed with thoracic malignancies, including pleural mesothelioma and lung cancer, at the Hollings Cancer Center.[1]
Dr. Boylan has spent years investigating diseases of the pleura and was enlisted as an authority in the product of the Center for Public Integrity’s 2010 document “Dangers in the Dust; Inside the Global Asbestos Trade.”[2]
Education and Career
Dr. Boylan earned her medical degree at the Lewis Katz School of Medicine at Temple University in Philadelphia, Pennsylvania.
She completed an internship and residency in Internal Medicine at Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital in Lebanon, New Hampshire, and then completed fellowships in Pulmonary Disease and Critical Care Medicine at the University of California at San Francisco.[3]
Dr. Boylan is currently a professor at the Medical University of South Carolina. She is the Chief of the Integrated Center of Clinical Excellence Medical Acute, Critical Care & Trauma and sees patients at a few locations in Charleston, South Carolina.
Dr. Boylan specializes in pulmonology and critical care. She treats a variety of illnesses of the lungs and chest, including lung cancer and pleural mesothelioma.
Professional Memberships
Dr. Boylan is a member of the American Thoracic Society and the American College of Critical Care Medicine. She has also participated in numerous committees, including:[3]
- Chairman of the American Thoracic Society’s ATS Respiratory Cell and Molecular Biology Program Committee
- American Thoracic Society’s Education Committee
- American Thoracic Society’s Maintenance of Certification Working Group
- Society of Critical Care Medicine’s Board Review Item Writing Committee
Research
Dr. Boylan has conducted extensive research into the impacts of asbestos on the human lung, including studies involving loss-of-function and gain-of-function experiments using sense and antisense strategies, as well as small inhibitory RNAs to determine whether asbestos specifically induces the expression of unique oncogenes.
Her most recent publications include:[3]
Development and Pilot of a Checklist for Management of Acute Liver Failure in the Intensive Care Unit. Oren K. Fix, Iris Liou, Constantine J. Karvellas, Daniel Ganger, Kimberly A. Forde, Ram Subramanian, Alice M. Boylan, James Hanje, R. Todd Stravitz, William M. Lee>; Plos One. 2016 May 13
Autophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models. Barbone D, Follo C, Echeverry N, Gerbaudo VH, Klabatsa A, Bueno R, Felley-Bosco E, Broaddus VC. PLoS One. 2015 Aug 18;10(8):e0134825. doi: 10.1371/journal.pone.0134825. PMID: 26284517; PMCID: PMC4540424.[4]
Field Walking Tests in Chronic Respiratory Disease/ Chris Garvey, Alice M. Boylan, David L. Miller, Anne E Holland, Sally J Singh, Martijn A. Spruit, Kevin C. Wilson, Carey C. Thomson>; Annals of the American Thoracic Society. 2015 Mar 18
Detection of human telomerase reverse transcriptase mRNA in cells obtained by lavage of the pleura is not associated with worse outcomes in patients with stage I/II non… Alice M. Boylan, Xiaofei Wang, Richard Ko, Patricia M. Watson, Lin Gu, David H. Harpole, Raphael Bueno, Rosemary F. Kelly, Leslie J. Kohman, Robert A. Kratzke>;The Journal of Thoracic and Cardiovascular Surgery. 2013 Jul 1
